Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|March 29, 2012
Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis CCalogero Cammà, Salvatore Petta, Marco Enea, et al.
Critical Reviews in Oncology/Hematology|November 26, 2015
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinomaFabrizio Bronte, Giuseppe Bronte, Daniele Fanale, et al.
Expert Opinion on Drug Safety|December 16, 2014
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapyGiuseppe Bronte, Enrico Bronte, Giuseppina Novo, et al.
World Journal of Gastroenterology|September 9, 2021
Naïve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective studyMar Riveiro-Barciela, Cristina Marcos-Fosch, Fernando Martinez-Valle, et al.
Haematologica|June 17, 2008
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis CVito Di Marco, Marcello Capra, Francesco Gagliardotto, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
The Influence of Additional Treatments on the Survival of Patients Undergoing Transarterial Radioembolization (TARE)Natale Quartuccio, Salvatore Ialuna, Daniele Scalisi, et al.
Journal of Hepatology|May 24, 2024
Agile scores in MASLD and ALD: External validation and their utility in clinical algorithmsMargarita Papatheodoridi, Victor De Ledinghen, Monica Lupsor-Platon, et al.
Journal of Hepatology|December 11, 2020
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver diseaseMargarita Papatheodoridi, Jean Baptiste Hiriart, Monica Lupsor-Platon, et al.
Pageof 3